HBOT Before and After Surgery: How Hyperbaric Oxygen Supports Surgical Recovery

Surgery creates a controlled injury. Whether it is a hip replacement, a spinal fusion, a breast reconstruction, or a facelift, the procedure involves cutting, retracting, and repairing tissue, and the quality of recovery depends substantially on the body's capacity to heal that tissue efficiently. Oxygen is central to that process.

Hyperbaric oxygen therapy is increasingly being used by patients and clinicians as a tool for surgical optimisation, both in the weeks before a procedure and in the recovery period that follows. The rationale is mechanistically straightforward, and a growing body of clinical evidence supports its use across a range of surgical contexts.

This article examines the evidence for HBOT in surgical recovery, the specific procedures where it has been most studied, and what patients and clinicians should understand before incorporating it into a surgical care plan.

Why Oxygen Is Central to Surgical Healing

Every stage of the healing process following surgery is oxygen-dependent. The inflammatory phase that begins immediately after tissue injury requires oxygen to fuel the cellular activity of neutrophils and macrophages clearing debris and initiating repair. The proliferative phase, in which fibroblasts lay down collagen and new blood vessels form, is critically dependent on oxygen availability. And the remodelling phase, in which collagen is reorganised and tissue regains its structural integrity, requires sustained oxygen delivery to the healing site.

The problem is that surgical trauma disrupts the local blood supply. Incisions, retraction, and tissue manipulation reduce perfusion in the operative field. Swelling compresses capillaries. Scar tissue formation can further impair oxygen delivery to healing tissue. The result is a zone of relative hypoxia at the surgical site, precisely where oxygen is most needed.

HBOT addresses this directly. By increasing the partial pressure of dissolved oxygen in plasma to levels that can reach poorly perfused tissue, it delivers oxygen to areas that the disrupted local circulation cannot adequately supply. It also stimulates angiogenesis, the growth of new blood vessels, which improves baseline perfusion over the course of treatment. And it has well-documented anti-inflammatory and antimicrobial effects that reduce the risk of infection and excessive inflammatory response in the post-operative period.

Pre-Operative HBOT: Optimising the Surgical Field

The use of HBOT before surgery, sometimes called pre-conditioning or pre-habilitation, is based on the principle that a tissue environment that is well-oxygenated and metabolically optimised before the surgical insult will heal more efficiently after it.

Pre-operative HBOT has been studied most extensively in patients with compromised tissue vascularity, including those with diabetes, peripheral vascular disease, or prior radiation to the surgical field. In these populations, the baseline tissue oxygen tension is already reduced, and the additional physiological stress of surgery creates a significant risk of poor healing, wound breakdown, and infection.

For patients with prior radiation to the surgical field, pre-operative HBOT is supported by the strongest evidence. Radiation causes progressive obliterative endarteritis, a process in which the small blood vessels in irradiated tissue are progressively destroyed, leaving the tissue chronically hypoxic and poorly capable of healing. The UHMS recognises osteoradionecrosis and soft tissue radionecrosis as established indications for HBOT, and the use of HBOT before surgery in previously irradiated tissue, to improve the vascularity of the operative field, is a well-established clinical practice.

For patients without prior radiation, the evidence for pre-operative HBOT is less definitive but mechanistically coherent. A course of HBOT in the weeks before major surgery may improve tissue oxygenation, reduce the inflammatory burden at the surgical site, and create conditions in which the healing response is more robust. Several centres offering elective surgical optimisation programmes incorporate pre-operative HBOT for this reason.

Orthopaedic Surgery: Hip and Knee Replacements

Total hip and knee replacement are among the most commonly performed elective surgical procedures, and they represent a significant physiological challenge. Both procedures involve substantial bone and soft tissue disruption, and recovery is measured in months rather than weeks. The quality of tissue healing in the early post-operative period has a direct bearing on functional outcomes, pain levels, and the risk of complications including infection and wound breakdown.

The evidence for HBOT in orthopaedic surgical recovery is primarily observational and mechanistic rather than from large randomised controlled trials, but the rationale is well supported. Bone healing is an oxygen-intensive process. Osteoblast activity, the cellular mechanism by which new bone is laid down, requires adequate oxygen delivery. Periosteal and endosteal vascularity, which supply the healing bone, can be compromised by surgical trauma and post-operative swelling.

HBOT's capacity to increase dissolved oxygen delivery to poorly perfused tissue, stimulate angiogenesis, and reduce post-operative inflammation makes it a physiologically coherent adjunct to orthopaedic recovery. Patients who have incorporated HBOT into their post-operative recovery following hip and knee replacement have reported reductions in swelling, improved pain management in the early recovery period, and subjective improvements in recovery trajectory, though well-powered prospective trials specifically in joint replacement populations remain limited.

For patients with risk factors that compromise healing, including diabetes, obesity, smoking history, or peripheral vascular disease, the case for HBOT as a post-operative adjunct is stronger. These are the patients most likely to experience delayed wound healing, superficial wound breakdown, and periprosthetic infection, and they are the patients in whom the oxygen-delivery benefits of HBOT are most likely to be clinically meaningful.

Spinal surgery, including lumbar fusion and cervical decompression procedures, presents a similar profile. Fusion procedures require bone graft incorporation and new bone formation across the fusion site, both of which are oxygen-dependent processes. Post-operative HBOT has been used in spinal surgery patients, particularly those with compromised vascularity or prior failed fusions, to support the metabolic demands of bone healing.

Plastic and Reconstructive Surgery

Plastic and reconstructive surgery represents the area where HBOT has the most established clinical evidence in a surgical context, and where its use is most widely accepted among specialist practitioners.

Flap Surgery and Tissue Transfer

The most extensively studied application of HBOT in plastic surgery is the salvage and support of compromised flaps. Flap surgery involves transferring tissue, either pedicled on its original blood supply or as a free flap with microvascular anastomosis, to reconstruct a defect. The transferred tissue is inherently at risk of ischaemia in the early post-operative period, as the new blood supply establishes itself and the tissue adapts to its new environment.

When a flap shows signs of ischaemia or venous congestion in the post-operative period, HBOT is used to increase oxygen delivery to the compromised tissue, reduce oedema, and support the metabolic demands of the tissue while the vascular supply stabilises. The UHMS recognises compromised skin grafts and flaps as an established indication for HBOT, and its use in this context is supported by a substantial body of clinical evidence.

A 2014 systematic review in the Annals of Plastic Surgery examined the evidence for HBOT in compromised flaps and grafts, finding consistent evidence of improved flap survival and reduced tissue loss in patients treated with HBOT compared to those who were not. The effect was most pronounced when HBOT was initiated early, within the first 24 to 48 hours of flap compromise.

Breast Reconstruction

Breast reconstruction following mastectomy, whether using implants, tissue expanders, or autologous tissue transfer such as TRAM or DIEP flaps, is a procedure in which tissue oxygenation is a critical determinant of outcome. Patients who have received prior radiation to the chest wall are at particularly high risk of complications, including capsular contracture, implant exposure, and flap necrosis, because the irradiated tissue has compromised vascularity.

HBOT is used in breast reconstruction both pre-operatively, to improve the vascularity of the irradiated field before reconstruction, and post-operatively, to support healing and reduce the risk of complications. Several plastic surgery centres with specialist expertise in post-radiation reconstruction have incorporated HBOT into their standard protocols for this patient group.

Aesthetic and Cosmetic Procedures

The use of HBOT in aesthetic surgery, including facelifts, rhinoplasty, abdominoplasty, and body contouring procedures, is less well studied in the formal research literature but is increasingly common in high-end cosmetic surgery practices, particularly those catering to patients who prioritise optimised recovery.

The rationale is the same as in reconstructive surgery: improved oxygen delivery to healing tissue, reduced post-operative swelling and bruising, and support for the collagen synthesis and tissue remodelling that determine the quality of the aesthetic outcome. Patients undergoing facelift surgery, in which skin flaps are elevated and repositioned, face a similar risk of flap ischaemia to those undergoing reconstructive flap procedures, and the same physiological principles apply.

Abdominoplasty and body contouring procedures involve significant undermining of skin and subcutaneous tissue, creating large areas of tissue that are dependent on the remaining blood supply. Post-operative HBOT has been used to support healing in these patients, particularly those with risk factors for wound complications.

The evidence in aesthetic surgery is primarily from case series and clinical experience rather than randomised controlled trials, and the field would benefit from more rigorous prospective research. But the mechanistic rationale is sound, and the clinical experience reported by practitioners who have incorporated HBOT into their post-operative protocols is consistently positive.

Cardiac Surgery

Cardiac surgery, including coronary artery bypass grafting and valve replacement procedures, involves significant physiological stress and a recovery process that places substantial demands on the body's healing capacity. Sternal wound complications, including superficial wound breakdown and deep sternal wound infection (mediastinitis), are among the most serious complications of cardiac surgery and carry significant morbidity and mortality.

HBOT has been used in the management of sternal wound complications following cardiac surgery, and the evidence in this context is reasonably well established. A 2016 review in the Journal of Wound Care examined the use of HBOT in post-sternotomy wound complications, finding consistent evidence of improved wound healing and reduced need for surgical re-intervention in patients treated with HBOT.

The use of HBOT prophylactically, before sternal wound complications develop, in high-risk cardiac surgery patients is less well studied but is an area of active clinical interest. Patients with diabetes, obesity, or prior chest radiation are at elevated risk of sternal wound complications, and pre-operative or early post-operative HBOT may reduce that risk by improving tissue oxygenation and reducing the inflammatory burden at the surgical site.

Maxillofacial and Dental Surgery

Oral and maxillofacial surgery, including jaw reconstruction, dental implant placement in compromised bone, and surgery in previously irradiated fields, represents one of the most established applications of HBOT in a surgical context.

Osteoradionecrosis of the jaw, a condition in which previously irradiated bone fails to heal following dental extraction or other surgical trauma, is an established UHMS indication for HBOT. The Marx protocol, developed by Dr Robert Marx and published in the 1980s, established the use of HBOT both before and after surgery in irradiated jaw bone, and this protocol remains the standard of care for this indication. The evidence base for HBOT in osteoradionecrosis is among the strongest in hyperbaric medicine.

For dental implant placement in patients with compromised bone vascularity, including those with prior radiation, bisphosphonate use, or poorly controlled diabetes, HBOT has been used to improve the osseointegration environment and reduce the risk of implant failure. The evidence in this context is primarily from case series and small prospective studies, but the mechanistic rationale is well supported.

What a Surgical HBOT Protocol Looks Like

The protocols used for surgical HBOT vary depending on the indication, the timing relative to surgery, and the clinical context.

For pre-operative conditioning, a typical course involves 20 sessions at 2.0 to 2.4 ATA, breathing 100% oxygen for 90 minutes per session, completed in the weeks before surgery. For post-operative recovery, sessions are typically initiated as soon as the patient is clinically stable, with the number of sessions ranging from 20 to 40 depending on the indication and the patient's response.

For compromised flaps and acute post-operative complications, HBOT is initiated urgently, often within hours of the complication being identified, and sessions may be conducted twice daily in the acute phase.

The timing of HBOT relative to surgery is an important consideration. Pre-operative sessions should ideally be completed close enough to the surgical date that the tissue conditioning effects are still present at the time of surgery, but not so close that the patient is fatigued or the logistics become unmanageable. Most protocols aim to complete the pre-operative course within two to four weeks of the planned surgical date.

Selecting the Right Facility

Not all hyperbaric facilities have experience with surgical applications of HBOT, and the quality of clinical oversight matters considerably in this context. A facility treating post-operative patients needs to understand the specific physiological demands of the surgical recovery period, the signs of post-operative complications that may require urgent intervention, and the coordination required with the surgical team.

For patients considering HBOT as part of a surgical recovery plan, the relevant questions include: does the facility have experience treating post-surgical patients; how do they coordinate with the surgical team; what protocol do they use and how is it tailored to the specific procedure; and what is their approach to monitoring and adjusting treatment based on the patient's response.

The relationship between the hyperbaric facility and the surgical team is not incidental. It is a meaningful indicator of the quality of care the patient will receive. HBOT used in isolation from the surgical context, without communication between the hyperbaric team and the operating surgeon, is not the same as HBOT integrated into a coordinated surgical recovery plan.

The Broader Picture

Surgery is one of the most physiologically demanding experiences the body undergoes, and the quality of recovery is not simply a matter of time. It is a matter of the biological conditions in which healing takes place. Oxygen is the most fundamental of those conditions.

HBOT's capacity to deliver oxygen to poorly perfused surgical tissue, stimulate the vascular and cellular mechanisms of healing, and reduce the inflammatory and infectious complications of surgery makes it a physiologically coherent and increasingly evidence-supported tool for patients who want to give their recovery the best possible foundation.

The evidence is strongest in reconstructive and plastic surgery, in previously irradiated tissue, and in patients with comorbidities that compromise healing. It is growing in orthopaedic and cardiac surgery. And it is being applied, with sound mechanistic rationale, in the aesthetic surgery context where formal trial evidence is still limited.

For anyone preparing for major surgery or managing a difficult post-operative recovery, understanding what HBOT can and cannot offer, and finding a facility with genuine expertise in surgical applications, is a worthwhile investment of time.